BC may has the potential to modulate the immunological response as well as the severity of the intestinal inflammatory reaction modulating TLR4 and cytokine expression, reducing BW loss and histological score, balancing the microbiota, and finally decreasing the clinical signs of colitis in mice. This evidence concerns the gene TLR4 and breast cancer.